Get started
Author

Di‐Hwei Hsu

Observed names: D H Hsu, D. H. Hsu, D.-H. Hsu, Di-Hwei Hsu
OpenAlex ID: A5024476824
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
1992 · F Rousset, E Garcia, et al. · Proceedings of the National Academy of Sciences · 1,247
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
2005 · Michael A Morse, Jennifer Garst, et al. · Journal of Translational Medicine · 1,150
PDF
Production and characterization of clinical grade exosomes derived from dendritic cells
2002 · Henry G Lamparski, Anita Metha-Damani, et al. · Journal of Immunological Methods · 738
Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
1990 · Di-Hwei Hsu, Rene de Waal Malefyt, et al. · Science · 545
Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells
2004 · Fabrice André, Nathalie Chaput, et al. · The Journal of Immunology · 512
A receptor for interleukin 10 is related to interferon receptors.
1993 · A S Ho, Y Liu, et al. · Proceedings of the National Academy of Sciences · 238
Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides
2003 · Di-Hwei Hsu, Pedro Paz, et al. · Journal of Immunotherapy · 169
HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1
1999 · Michael S. Cole, Karl E. Stellrecht, et al. · Transplantation · 84
A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex‐specific monoclonal antibody
1996 · Susan Eastman, Michael Deftos, et al. · European Journal of Immunology · 59
A HUMANIZED ANTI-CD3 ANTIBODY, HuM291, WITH LOW MITOGENIC ACTIVITY, MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES
1999 · Di-Hwei Hsu, Jia Dong Shi, et al. · Transplantation · 45
Pharmacology and Safety Assessment of Humanized Monoclonal Antibodies for Therapeutic Use
1999 · Corine Klingbeil, Di-Hwei Hsu · Toxicologic Pathology · 34
A predominant idiotype independent of specificity, or Ig and H‐2 allotypes, is found in the primary but not the secondary murine antibody response to lysozyme
1988 · Mark A. Kaplan, Margaret A. Keller, et al. · European Journal of Immunology · 8
Aberrant Expression of Gap-43 in Alzheimerʼs Disease (ad)
1990 · S. M. de la Monte, S-C Ng, et al. · Journal of Neuropathology & Experimental Neurology · 2
A Validated Potency Assay for Dexosomes, a Novel Acellular Product for Cancer Therapy
2004 · Pedro Paz, Gayatri Paranjpe, et al. · Journal of Immunotherapy · 1
Structure and expression of cloned Fcγ receptors
1990 · K.W. Moore, D.-H. Hsu · Research in Immunology · 1
A HUMANIZED ANTI-CD3 ANTIBODY HuM291 MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES
1999 · Di-Hwei Hsu, Jia Dong Shi, et al. · Transplantation
A Tale of Two Idiotypes: Different Predominant Idiotypes in the Primary and Secondary Responses to Hen Eggwhite Lysozyme
1986 · Mark Kaplan, Lean-Kuan Ch'ng, et al. · Elsevier eBooks
Works count: 17
Citation count: 4,833
H-index: 11
I10-index: 11
Year
Topic
Type